Dashboard
Manage Tickers

IMNM Immunome Inc.

Nasdaq immunome.com


$ 17.22 $ 0.63 (3.82 %)    

Friday, 14-Nov-2025 15:54:40 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 613.29 $ 0.00 (0 %)
DIA $ 472.34 $ 0.00 (0 %)
SPY $ 675.00 $ 0.00 (0 %)
TLT $ 89.20 $ 0.00 (0 %)
GLD $ 375.58 $ 0.00 (0 %)
$ 17.14
$ 16.11
$ 17.14 x 33
$ 17.65 x 675
-- - --
$ 5.15 - $ 18.46
2,006,556
na
1.57B
$ 1.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-19-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-05-2023 03-31-2023 10-Q
12 03-16-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-28-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

immunome-q3-eps-065-misses-058-estimate
Immunome Q3 EPS $(0.65) Misses $(0.58) Est...
11/06/2025 22:10:29

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.58) by...

immunome-presented-preclinical-data-showing-its-proprietary-antibody-drug-conjugate-payload-hc74-overcomes-multiple-mechanisms-of-adc-resistance-including-payload-efflux-and-target-heterogeneity-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics
Immunome Presented Preclinical Data Showin...
10/23/2025 16:02:39

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer th...

where-immunome-stands-with-analysts
Where Immunome Stands With Analysts
09/22/2025 18:01:44

this-crocs-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-monday
This Crocs Analyst Is No Longer Bullish; H...
09/22/2025 14:42:08

this-gatx-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This GATX Analyst Begins Coverage On A Bul...
09/22/2025 12:53:05

goldman-sachs-initiates-coverage-on-immunome-with-buy-rating-announces-price-target-of-26
Goldman Sachs Initiates Coverage On Immuno...
09/22/2025 11:57:24

Goldman Sachs analyst Salveen Richter initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Tar...

infinimmune-enters-research-collaboration-with-immunome-under-which-immunome-will-receive-target-exclusivity
Infinimmune Enters Research Collaboration ...
09/18/2025 12:07:47

where-immunome-stands-with-analysts
Where Immunome Stands With Analysts
09/05/2025 21:02:15

craig-hallum-initiates-coverage-on-immunome-with-buy-rating-announces-price-target-of-26
Craig-Hallum Initiates Coverage On Immunom...
09/05/2025 14:05:27

Craig-Hallum analyst Adam Vogel initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target of...

guggenheim-reiterates-buy-on-immunome-maintains-25-price-target
Guggenheim Reiterates Buy on Immunome, Mai...
08/25/2025 14:27:45

Guggenheim analyst Michael Schmidt reiterates Immunome (NASDAQ:IMNM) with a Buy and maintains $25 price target.

this-netgear-analyst-begins-coverage-on-a-bullish-note-here-are-top-4-initiations-for-friday
This Netgear Analyst Begins Coverage On A ...
08/22/2025 19:18:27

evercore-isi-group-initiates-coverage-on-immunome-with-outperform-rating-announces-price-target-of-18
Evercore ISI Group Initiates Coverage On I...
08/22/2025 16:50:26

Evercore ISI Group analyst Cory Kasimov initiates coverage on Immunome (NASDAQ:IMNM) with a Outperform rating and announces ...

jp-morgan-maintains-overweight-on-immunome-lowers-price-target-to-22
JP Morgan Maintains Overweight on Immunome...
08/07/2025 21:12:07

JP Morgan analyst Brian Cheng maintains Immunome (NASDAQ:IMNM) with a Overweight and lowers the price target from $23 to $22.

immunome-q2-eps-050-beats-055-estimate-sales-4015m-may-not-be-comparable-to--714286k-estimate
Immunome Q2 EPS $(0.50) Beats $(0.55) Esti...
08/06/2025 20:54:27

immunome-q1-eps-052-beats-068-estimate-sales-293m-beat-28571k-estimate
Immunome Q1 EPS $(0.52) Beats $(0.68) Esti...
05/12/2025 20:26:47

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.68) by 2...

lake-street-initiates-coverage-on-immunome-with-buy-rating-announces-price-target-of-23
Lake Street Initiates Coverage On Immunome...
04/02/2025 13:04:40

Lake Street analyst Chad Messer initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target of...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/26/2025 21:05:44

wedbush-reiterates-outperform-on-immunome-maintains-33-price-target
Wedbush Reiterates Outperform on Immunome,...
03/20/2025 14:58:18

Wedbush analyst David Nierengarten reiterates Immunome (NASDAQ:IMNM) with a Outperform and maintains $33 price target.

stephens--co-reiterates-overweight-on-immunome-maintains-30-price-target
Stephens & Co. Reiterates Overweight on Im...
03/20/2025 13:52:54

Stephens & Co. analyst Sudan Loganathan reiterates Immunome (NASDAQ:IMNM) with a Overweight and maintains $30 price target.

guggenheim-maintains-buy-on-immunome-lowers-price-target-to-25
Guggenheim Maintains Buy on Immunome, Lowe...
03/20/2025 13:31:14

Guggenheim analyst Michael Schmidt maintains Immunome (NASDAQ:IMNM) with a Buy and lowers the price target from $35 to $25.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION